美国国家卫生研究所是世界最大的生物医学研究投资方。
It pays for risky basic science; companies pay for later stages of development.
对于成功率较低的基础科学,开始阶段的研究由研究会买单,而后阶段的开发则由各大公司支付。
For example, the NIH supported early research into monoclonal antibodies.
比如,NIH支付了单克隆抗体早期的研发费用。
By 2010 such research underpinned five of America s 20 bestselling drugs.
截至2010年,美国最畅销的20种药物中,有5种来自于这种方式。
As drug firms trim their budgets, the NIH s work is becoming even more vital.
药物公司的预算减少,NIH的作用就更加重要了。
But since 2003, inflation-adjusted spending on medical research has declined.
然而,由于通胀所迫,医学研究经费自2003年起也有所下降。
With the sequester public investment will shrink further.
由于财政封存,国家投资将进一步减少。
America s total outlay on RD will drop by 8.7 billion this year, according to the AmericanAssociation for the Advancement of Science.
据美国科学发展协会称,今年美国在研发上的总支出会减少87亿美元。
【2015考研英语阅读美国研发战略】相关文章:
最新
2016-10-18
2016-10-11
2016-10-11
2016-10-08
2016-09-30
2016-09-30